| Literature DB >> 27839656 |
H-L Tan1, D S Urquhart2.
Abstract
Prader Willi syndrome, resulting from the partial deletion or lack of expression of a region of genes on the paternal chromosome 15, has a number of phenotypic features which predispose affected patients to ventilatory problems. These include generalised hypotonia, abnormal arousal and ventilatory responses to hypoxia and hypercapnia, scoliosis and frequently, obesity. The spectrum of the resulting respiratory complications thus runs from sleep disordered breathing, to aspiration and respiratory functional impairment. While the use of growth hormone, in conjunction with multidisciplinary clinical management, is currently the cornerstone of clinical care of these patients, concerns have been raised following reports of sudden death shortly after growth hormone initiation. This review summarizes the respiratory complications commonly seen and draws together the published literature on the impact of growth hormone in relation to various respiratory parameters, aiming to provide the reader with the necessary information to manage these patients as safely as possible.Entities:
Keywords: Prader Willi syndrome; aspiration; growth hormone; sleep disordered breathing
Mesh:
Substances:
Year: 2016 PMID: 27839656 DOI: 10.1016/j.prrv.2016.08.002
Source DB: PubMed Journal: Paediatr Respir Rev ISSN: 1526-0542 Impact factor: 2.726